Physician profile
Sarah Townsley Ridenour
NPI 1427686468
$33,724.64
in general payments reported to CMS, 2019-2025
10 companies · $31K in 2025
The $31K reported for 2025 was more than what 98% of Surgery of The Hand (Surgery) providers received nationally (typical 2025 total: $285).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $310 · 2022: $790 · 2023: $686 · 2024: $932 · 2025: $31K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $30K · Food and Beverage: $2,504 · Travel and Lodging: $121.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $30,000.00 |
| Food and Beverage | $2,503.52 |
| Travel and Lodging | $121.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acumed LLC | $20,000.00 | 2025 | |
| Arthrex, INC. | $10,000.00 | 2025 | |
| Stryker Corporation | $2,028.89 | 2021-2025 | Gamma, Pangea, Variax |
| Depuy Synthes Sales INC. | $609.51 | 2022-2025 | Tfn-Advance, Na |
| Axogen | $483.38 | 2022-2025 | Avance Nerve Graft |
| Foundation Medical, LLC | $172.92 | 2023 | |
| Integra Lifesciences Corporation | $163.51 | 2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Aptis Medical, LLC | $133.76 | 2023 | Aptis Druj |
| Osteocentric Technologies, INC. | $119.99 | 2022-2024 | Osteocentric 4.0 X 130mm Locking Bone Screw Fastener St |
| Endo Pharmaceuticals INC. | $12.68 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sarah Ridenour listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.